Table 3 from Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC
Year: 2024
Type: other
Abstract: Pathologic outcomes at time of surgery in patients who underwent ICI-based neoadjuvant therapy or upfront resection for HCC
Authors: Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith, Robert A. Anders, Kiyoko Oshima, Amy K. Kim, Jacqueline Laurin, Kelly J. Lafaro, Christopher R. Shubert, William R. Burns, Jin He, Richard A. Burkhart, Benjamin Philosophe, Jeffrey Meyer, Robert P. Liddell, Christos Georgiades, Kelvin Hong, Won Jin Ho, Marina Baretti, Alexandra T. Strauss, Mark Yarchoan
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4401626007